BioMed Research International

Biomarkers of Brain Function and Injury: Biological and Clinical Significance

Publishing date
14 Nov 2014
Submission deadline
27 Jun 2014

Lead Editor

1Neonatal Intensive Care Unit, Department of Pediatrics, C. Arrigo Children's Hospital, Alessandria, Italy

2Department of Biological Chemistry, Medical Chemistry and Molecular Biology, University of Catania, Catania, Italy

3Department of Pediatrics and Neonatology, Maastricht University, LB Maastricht, The Netherlands

4Department of Health Sciences, University of Molise, Campobasso, Italy

Biomarkers of Brain Function and Injury: Biological and Clinical Significance


There is growing evidence that biomarkers will constitute a useful source for further investigations on CNS development, function, and damage. However, several crucial points before their inclusion in clinical guidelines need to be addressed. The solution resides in multidisciplinary cooperation among neonatologists, pediatricians, biochemists, neuroscientists, and last but not least manufacturers.

In the last decades, several novel molecules have been suggested to be reliable biomarkers to predict outcomes in adults, children, neonates, and fetuses. This holds for brain trauma and brain insults, which have been compared with functional/clinical scores or measures of neuropsychological impairment.

According to the main known pathophysiological steps leading to brain bleeding and/or damage, investigations aim at clarifying biomarkers role as predictors of damage and localization and extension of the lesion in adult and pediatric and perinatal periods are eagerly awaited. Potential topics include, but are not limited to:

  • Biomarkers in experimental animal model with particular regard to hypoxia reperfusion injury and preconditioning
  • Biomarkers of brain damage in relation to standard monitoring techniques (i.e., MRI, EEG, etc.)
  • Biomarkers of the localization and extent of the brain lesion (clinical and experimental)
  • Biomarkers of CNS functions (clinical and experimental)
  • Biomarkers of the effectiveness of therapeutic strategies (clinical and experimental)
  • Biomarkers in stroke and tumors
  • Biomarkers in neurodegenerative disease

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:


  • Special Issue
  • - Volume 2015
  • - Article ID 402959
  • - Review Article

Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update

Dariusz Tomaszewski
  • Special Issue
  • - Volume 2015
  • - Article ID 718591
  • - Research Article

Sustained Reduction of Cerebellar Activity in Experimental Epilepsy

Kim Rijkers | Véronique M. P. Moers-Hornikx | ... | Govert Hoogland
  • Special Issue
  • - Volume 2015
  • - Article ID 276029
  • - Research Article

Intra-Amniotic LPS Induced Region-Specific Changes in Presynaptic Bouton Densities in the Ovine Fetal Brain

Eveline Strackx | Reint K. Jellema | ... | Antonio W. D. Gavilanes
  • Special Issue
  • - Volume 2015
  • - Article ID 402642
  • - Clinical Study

Circulating S100B and Adiponectin in Children Who Underwent Open Heart Surgery and Cardiopulmonary Bypass

Alessandro Varrica | Angela Satriano | ... | Diego Gazzolo
  • Special Issue
  • - Volume 2014
  • - Article ID 282490
  • - Research Article

Decreased Fast Ripples in the Hippocampus of Rats with Spontaneous Recurrent Seizures Treated with Carbenoxolone and Quinine

Consuelo Ventura-Mejía | Laura Medina-Ceja
  • Special Issue
  • - Volume 2014
  • - Article ID 981219
  • - Review Article

Clinical Metabolomics and Nutrition: The New Frontier in Neonatology and Pediatrics

Angelica Dessì | Flaminia Cesare Marincola | ... | Vassilios Fanos
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
Impact Factor2.276